:: BioSignia :: Patented technology; chronic disease Health Risk-Risk Reduction Assessment communication tools and healthcare claims analysis technology.

About BioSignia

BioSignia™ is the leading provider of chronic disease health risk assessment services. Our patented technology combines laboratory results, demographics, clinical observations, and lifestyle indicators to measure each individual’s unique health status. BioSignia’s award winning experts bring international wisdom to the table, going the distance to promote good health worldwide.

Dr. Guizhou Hu, BioSignia, V.P. R&D
Dr. Guizhou Hu, BioSignia, V.P. Research & Development Awarded Triangle Business Journal’s Health Care Hero Award in the Category of Innovation
>ReadMore

BioSignia Part of IHPM/Abbott Initiative in China
BioSignia, Abbott, and IHPM, in association with WellTech and Huadong Hospital have combined resources to bring the first preventive and active-stage diabetes management program to employers in China.
>ReadMore

BioSignia Names Medical Director
BioSignia is pleased to announce the addition of George Mayzell, MD as Medical Director. Dr. Mayzell is a Board Certified internist and Geriatrician with over 10 years of direct patient care experience and 15 years of Health Industry leadership.
>ReadMore

BioSignia, Inc. • 1822 East NC Highway 54, Suite 350 • Durham, NC 27713 • (919) 933-2021 • (888) 324-6627